Citations Affected: IC 12-23-18.
Synopsis: Opioid treatment. Conference committee report for ESB 450. Adds a $30 resident
methadone clinic patient fee and increases the fee for nonresident methadone clinic patients from
$20 to $150. Specifies uses for the methadone diversion control and oversight program fund.
Extends the expiration date for the methadone diversion and control oversight program from June
30, 2008, to June 30, 2010. Places a moratorium on new opioid treatment programs until
December 31, 2008. Requires the division of mental health and addiction (division) to: (1)
compare other state regulations of methadone clinics with Indiana regulations; (2) address
concerns that have been raised concerning Indiana's regulation of methadone clinics; and (3)
prepare a report to be submitted to the health finance commission and the general assembly;
before July 1, 2007. Requires the director of the division to testify before the health finance
commission, and requires the health finance commission to study the adequacy of Indiana's
methadone clinic regulations during the 2007 interim. Repeals a provision that allows new
methadone providers under certain circumstances. (This conference committee report: (1)
adds a $30 fee for Indiana resident and $150 fee for nonresident methadone clinic patients;
(2) specifies uses for the methadone diversion control and oversight program fund; and (3)
extends the expiration date for the methadone diversion and control oversight program
from June 30, 2008, to June 30, 2010.)
Effective: July 1, 2007.
Your Conference Committee appointed to confer with a like committee from the House upon Engrossed House Amendments to Engrossed Senate Bill No. 450 respectfully reports that said two committees have conferred and agreed as follows to wit:
that the Senate recede from its dissent from all House amendments and that
the Senate now concur in all House amendments to the bill and that the bill
be further amended as follows:
may also be used for the following:
(1) To support technical assistance to health providers who provide assistance concerning the following:
(A) Methadone and other medication assisted therapy.
(B) Evidence based addiction treatment.
(C) Interventions and treatment of individuals suffering with co-existing disorders of mental illness and substance abuse addiction disorders.
(2) To include methadone providers in the quality review process of reviewing methadone consumer services.
(3) To provide mental health and addiction prevention and treatment services to consumers.
(c) The expenses of administering the fund shall be paid from money in the fund.
(d) The treasurer of state shall invest money in the fund in the same manner as other public money may be invested.
(e) Money in the fund at the end of the state fiscal year does not revert to the state general fund.".
Senator MillerRepresentative Stemler
Senator SipesRepresentative Crouch
Senate Conferees House Conferees